You are here:

Home
NICE Guidance
Published Guidance

Eculizumab for treating refractory myasthenia gravis (terminated appraisal)

Technology appraisal
Reference number: TA636
Published: 30 June 2020

Guidance
Tools and resources
History

Tools and resources

Tools to help you put the guidance into practice.

Guidance into practice

About the Into practice guide
Practical steps to improving the quality of care and services using NICE guidance